Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting Nav1.7 and Nav1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain

Neurobiology of Pain(2024)10.1016/j.ynpai.2024.100174Source: DataRank Database

Targeting Nav1.7 and Nav1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain is a research paper published in Neurobiology of Pain (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.17)OA: goldTopics (16)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Santiago Loya‐López ORCID,Sophia M. Min ORCID,Aida Calderón‐Rivera ORCID,Kimberly Gómez ORCID,Rajesh Khanna ORCID

Live enrichment

PubMed:39720155 PMC:PMC11665415 OpenAlex:https://openalex.org/W4404839215

NINDS NIH HHS

Grant: R01 NS098772

NIDA NIH HHS

Grant: R01 DA042852

NINDS NIH HHS

Grant: R01 NS120663

National Institutes of Health

Grant: 3R01NS120663-01A1S2

CRMP2 Phosphorylation: A Novel Target for Alzheimer's Disease?

National Institutes of Health

Grant: 1R01DA042852-01A1

CRMP2, Nav1.7 sodium channel, and chronic pain

National Institutes of Health

Grant: 5R01NS098772-03

CRMP2, mitochondria, and Huntington’s disease

National Institute on Drug Abuse

National Institute of Neurological Disorders and Stroke

FWCI

1.17

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ynpai.2024.100174

publisherhttps://doi.org/10.1016/j.ynpai.2024.100174

publisherhttps://api.elsevier.com/content/article/PII:S2452073X24000254?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2452073X24000254?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39720155

Fields of Study

Pain Mechanisms and TreatmentsPharmacological Receptor Mechanisms and EffectsAdenosine and Purinergic Signaling

Keywords

NAV1Neuropathic painMedicinePharmacologyNeurosciencePsychologyChemistrySodium channelSodium channelsPharmacokineticsSensory NeuronsPikfyve InhibitorOriginal Research Article

Sustainable Development Goals

SDG 0: Good health and well-being